Transfection and functional expression of CYP4A1 and CYP4A2 using bicistronic vectors in vascular cells and tissues

Journal of Pharmacology and Experimental Therapeutics

Volumn 311, Issue 3, 2004, Pages 913-920

  Wang, Ji Shi ^a   Zhang, Fan ^a   Jiang, Miao ^a   Wang, Mong Heng ^b   Zand, Barbara A ^a   Abraham, Nader G ^a   Nasjletti, Alberto ^a   Laniado Schwartzman, Michal ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; AMIDE; ARACHIDONIC ACID DERIVATIVE; BROMINE DERIVATIVE; COMPLEMENTARY DNA; CYTOCHROME P450; CYTOCHROME P450 4A1; CYTOCHROME P450 4A2; CYTOCHROME P450 INHIBITOR; GREEN FLUORESCENT PROTEIN; METHYL GROUP; N METHYLSULFONYL 12,12 DIBROMODODEC 11 ENAMIDE; PHENYLEPHRINE; SULFONE DERIVATIVE; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT;

ADVENTITIA; ANIMAL CELL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME MECHANISM; EXPRESSION VECTOR; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; HYDROXYLATION; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; INTERNAL RIBOSOME ENTRY SITE; INTIMA; KIDNEY CIRCULATION; METABOLITE; MICROCIRCULATION; MICRODISSECTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT; SENSITIZATION; VASCULAR SMOOTH MUSCLE; VASCULAR TISSUE; VASOCONSTRICTION; WESTERN BLOTTING;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ARACHIDONIC ACID; ARTERIES; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOCHROME P-450 ENZYME SYSTEM; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HYDROXYEICOSATETRAENOIC ACIDS; ISOMETRIC CONTRACTION; LAURIC ACIDS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; TRANSFECTION;

EID: 10044298331     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.070979     Document Type: Article

References (28)

1. Alonso-Galicia M, Falck JR, Reddy KM, and Roman RJ (1999) 20-HETE agonists and antagonists in the renal circulation. Am J Physiol 277:F790-F796.
2. Buus NH, Simonsen U, Pilegaard HK, and Mulvany MJ (2000) Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries. Br J Pharmacol 129:184-192.
3. Campbell WB and Harder DR (1999) Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ Res 84:484-488.
4. Campbell WB, Spitzbarth N, Gauthier KM, and Pfister SL (2003) 11,12,15-Trihydroxyeicosatrienoic acid mediates ACh-induced relaxations in rabbit aorta. Am J Physiol Heart Circ Physiol 285:H2648-H2656.
5. Chen JK, Wang DW, Falck JR, Capdevila J, and Harris RC (1999) Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor. J Biol Chem 274:4764-4769.
6. Cowart LA, Wei S, Hsu MH, Johnson EF, Krishna MU, Falck JR, and Capdevila JH (2002) The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J Biol Chem 277:35105-35112.
7. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, and Busse R (1999) Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature (Lond) 401:493-497.
8. Fleming I, Fisslthaler B, Michaelis UR, Kiss L, Popp R, and Busse R (2001) The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signaling pathways and proliferation in vascular cells. Pflugers Arch 442:511-518.
9. 2+ current. J Physiol 507:771-781.
10. Imig JD, Zou A-P, Stec DE, Harder DR, Falck JR, and Roman RJ (1996) Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 270:R217-R227.
11. Kaide J-I, Wang M-H, Wang J-S, Zhang F, Gopal VR, Falck JR, Nasjletti A, and Laniado-Schwartzman M (2003) Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries. Am J Physiol Renal Physiol 284:F51-F56.
12. Li PL, Zou AP, and Campbell WB (1997) Regulation of potassium channels in coronary arterial smooth muscle by endothelium-derived vasodilators. Hypertension 29:262-267.
13. Lin F, Rios A, Falck JR, Belosludtsev Y, and Laniado Schwartzman M (1995) 20-hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am J Physiol 269:F806-F816.
14. Ma Y-H, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BSS, Harder DR, and Roman RJ (1993) 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72:126-136.
15. Marji JS, Wang MH, and Laniado-Schwartzman M (2002) Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries. Am J Physiol Renal Physiol 283:F60-F70.
16. Michaelis UR, Fisslthaler B, Medhora M, Harder D, Fleming I, and Busse R (2003) Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR). FASEB J 17:770-772.
17. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR, and Malik KU (1998) 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin- dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 95:12701-12706.
18. Nguyen X, Wang MH, Reddy KM, Falck JR, and Schwartzman ML (1999) Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Am J Physiol 276:R1691-R1700.
19. +-ATPase. J Clin Investig 99:1224-1230.
20. Okita RT and Okita JR (2001) Cytochrome P450 4A fatty acid omega hydroxylases. Curr Drug Metab 2:265-281.
21. Paine AJ (1991) The cytochrome P450 gene superfamily Int J Exp Pathol 72:349-363.
22. Sirica AE and Pitot HC (1979) Drug metabolism and effects of carcinogens in cultured hepatic cells. Pharmacol Rev 31:205-228.
23. Sun CW, Falck JR, Harder DR, and Roman RJ (1999) Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 33:414-418.
24. Wang M-H, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, and Laniado Schwartzman M (1998a) Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J Pharmacol Exp Ther 284:966-973.
25. Wang M-H, Guan H, Nguyen X, Zand B, Nasjletti A, and Laniado-Schwartzman M (1998b)Contribution of cytochrome P450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in the rat kidney. Am J Physiol 276:F246-F253.
26. Wang M-H, Stec DE, Balazy M, Mastyugin V, Yang CS, Roman RJ, and Laniado Schwartzman M (1996) Cloning, sequencing and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid ω-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Arch Biochem Biophys 336:240-250.
27. Zhang F, Wang MH, Krishna UM, Falck JR, Laniado-Schwartzman M, and Nasjletti A (2001) Modulation by 20-HETE of phenylephrine-induced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 38:1311-1315.
28. + channel in renal arterioles. Am J Physiol 270:R228-R237.